VTRS Stock Analysis: Buy, Sell, or Hold?
VTRS - Viatris Inc. Common Stock
$16.31
-0.09 (-0.52%)
▼
5d:
-3.86%
30d:
-0.03%
90d:
+17.9%
BUY
MODERATE Confidence
Analysis Updated: Jul 14, 2026 12:00 AM ET
Earnings: Aug 06, 2026
22d
Smart Money Accumulation
None View Scanner →
Strength: 7.0/10
Get Alerted When VTRS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: VTRS shows positive signals but monitor for confirmation. Market pricing in 3.6% growth. Moderate conviction.
💡 BUY OPPORTUNITY: VTRS shows positive signals but monitor for confirmation. Market pricing in 3.6% growth. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$19.91
Based on 6.4% avg growth
INTRINSIC VALUE TODAY
$12.36
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 5.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: VTRS is currently trading at $16.30, which is considered fair relative to its 30-day fair value range of $15.77 to $16.55. From a valuation perspective, the stock is trading at a premium (Forward PE: 6.2) compared to its historical average (5.5). At these levels, the market is pricing in 3.6% annual earnings growth.
Technical Outlook: Technically, VTRS is in a strong uptrend. Immediate support is located at $15.79, while resistance sits at $17.16.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, VTRS is in a strong uptrend. Immediate support is located at $15.79, while resistance sits at $17.16.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$15.77 -
$16.55
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
71.0%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($17.81)
- BULLISH: Expecting earnings turnaround to 3.6% growth with 8.1% revenue growth
Trading Range Analysis
30-Day Trading Range
$15.77 -
$16.55
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$15.80
Resistance Level
$17.17
Current Trend
Strong Uptrend
Technical data as of
Jul 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
6.16
Wall Street Target
$17.81
(+8.7%)
Revenue Growth (YoY)
8.1%
Earnings Growth (YoY)
-70.6%
Profit Margin
-2.0%
Valuation Premium vs History
+3.6% premium
PE vs Historical
6.2 vs 5.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.6%
(market-implied from PE analysis)
1-Year Target
$16.98
(+4%)
2-Year Target
$17.59
(+7%)
3-Year Target
$18.22
(+11%)
3-Yr Target (if PE normalizes)
(PE: 6→6)
PE COMPRESSION
$16.28
(-1%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 8.7%)
$74.43
(+354%)
Base:
(SPY PE: 6.2, Growth: 8.7%)
$21.04
(+28%)
Bear:
(PE: 5.2, Growth: 8.7%)
$17.88
(+9%)
Share & Embed Analysis
Last updated: July 14, 2026 3:33 PM ET
Data refreshes hourly during market hours. Next update: 4:33 PM
Data refreshes hourly during market hours. Next update: 4:33 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VTRS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Paul Campbell
SELL
21350 shares
2026-03-23
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$198 | 58 HOLD |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$116 | 59 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$110 | 58 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$664 | 58 HOLD |
|
HCM
HUTCHMED DRC |
STRONG BUY
14 analysts |
$23 | 54 HOLD |
Advanced VTRS Option Strategies
Professional options setups generated by AI based on today's VTRS price and gamma walls.
